[Zoledronic acid free adjustment according to renal function: results of pharmacists interventions].
Mora Atorrasagasti
O
O
Lertxundi Etxeberria
U
U
Peral Aguirregoitia
J
J
Martínez Bengoechea
M J
MJ
D050071:Bone Density Conservation Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D004164:Diphosphonates / Q000494:pharmacology* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D017408:Guidelines as Topic; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D010595:Pharmacists; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid